Gamida Cell Gears Up For Omidubicel Submission
Seeks Partners For Bone Marrow Transplant Cell Therapy
Executive Summary
With funding drying up for biotechs as sentiment continues to turn against the sector, Israel-headquartered Gamida Cell is cutting jobs and putting out feelers for potential partners to take its promising cell therapy to market.